CompletedNot Applicable

Single-Session Extraoral PBM After Third Molar Extraction

Turkey (Türkiye)70 participantsStarted 2025-02-15

Plain-language summary

Postoperative pain, edema, and trismus are frequent complications following impacted mandibular third molar surgery. This randomized controlled trial evaluated the effects of a single-session extraoral dual-wavelength photobiomodulation (PBM) (650+904 nm) applied immediately after extraction. The study aimed to assess the impact of this therapy on postoperative pain, edema, trismus, and quality of life (QoL) on days 2 and 7. The results indicate that PBM effectively reduces early postoperative pain and improves QoL on the second day after surgery, although it does not significantly affect edema or trismus.

Who can participate

Age range17 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Indication for extraction of an impacted mandibular third molar in the mesioangular position. * Asymptomatic tooth in Pell-Gregory Class IB position. * Absence of systemic disease (ASA I status). * Healthy status of the impacted tooth and surrounding tissues. * Adequate oral hygiene. * Absence of malignant or premalignant oral lesions. Exclusion Criteria: * Pregnancy or lactation. * Regular use of non-steroidal anti-inflammatory drugs or antibiotics within the preceding week. * Presence of a diagnosed psychiatric disorder. * Active smoking.

What they're measuring

Postoperative Pain

Timeframe: Baseline, Postoperative Day 2, and Postoperative Day 7.

Trial details

NCT IDNCT07522918

SponsorKonya Necmettin Erbakan Üniversitesi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-20

View on ClinicalTrials.gov More Impacted Mandibular Third Molar trials